Trial site
Asclepius Medical Center OOD
- 18running trials
- 18closed trials
The trials here
What the 36 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)7 trials
- COPD7 trials
- Asthma5 trials
- Vitiligo5 trials
- Chronic spontaneous urticaria3 trials
- Psoriasis3 trials
- Schizophrenia2 trials
- Atrial fibrillation1 trial
- Hidradenitis suppurativa1 trial
- Obesity1 trial
- Phase
- Phase 325 trials
- Phase 28 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Completed18 trials
- Active, not recruiting10 trials
- Recruiting7 trials
- Not yet recruiting1 trial
- Lead sponsor
- AstraZeneca4 trials
- Sanofi4 trials
- Incyte Corporation3 trials
- Pfizer3 trials
- Takeda3 trials
- and 17 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma2 recruiting
- Chronic spontaneous urticaria2 recruiting
- COPD2 recruiting
- Hidradenitis suppurativa1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Completed
Completed
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Not yet recruiting
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026